Retinal cases & brief reports · 2026
SYMMETRIC BILATERAL MACULAR ATROPHY IN MUCOLIPIDOSIS TYPE 3: A RARE MANIFESTATION.
СтатьяКлинический случайНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Dourado Fernanda Galante, Omote Daniel Queiroz, de Pinho Paula Dandara Correia, Pimentel Sergio Luis Gianotti
Аннотация
PURPOSE: Describe a case of symmetric bilateral macular atrophy as an ophthalmologic manifestation of Mucolipidosis type 3.
METHODS: Multimodal retinal imaging evaluation was performed, with color fundus photograph, fundus autofluorescence, fluorescein angiography, and optical coherence tomography. Genetic testing confirmed the systemic diagnosis.
RESULTS: Genetic testing confirmed the diagnosis of Mucolipidosis type 3, and macular bilateral atrophy was considered a rare manifestation of the systemic disease.
DISCUSSION: Ophthalmologic manifestations in mucolipidosis are rare, with corneal opacities being most reported. Our patient presented bilateral macular atrophy, which had not been previously described in association with the disease, and is important to consider different diagnosis.
CONCLUSION: It is important to consider different diagnosis, such as retinal dystrophies and conditions causing macular atrophy, and this case highlights the importance of considering rare ophthalmologic manifestations in syndromic diseases.
METHODS: Multimodal retinal imaging evaluation was performed, with color fundus photograph, fundus autofluorescence, fluorescein angiography, and optical coherence tomography. Genetic testing confirmed the systemic diagnosis.
RESULTS: Genetic testing confirmed the diagnosis of Mucolipidosis type 3, and macular bilateral atrophy was considered a rare manifestation of the systemic disease.
DISCUSSION: Ophthalmologic manifestations in mucolipidosis are rare, with corneal opacities being most reported. Our patient presented bilateral macular atrophy, which had not been previously described in association with the disease, and is important to consider different diagnosis.
CONCLUSION: It is important to consider different diagnosis, such as retinal dystrophies and conditions causing macular atrophy, and this case highlights the importance of considering rare ophthalmologic manifestations in syndromic diseases.